<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urmj</journal-id><journal-title-group><journal-title xml:lang="ru">Уральский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Ural Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-4389</issn><publisher><publisher-name>Ural State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52420/2071-5943-2023-22-6-104-112</article-id><article-id custom-type="elpub" pub-id-type="custom">urmj-1373</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Влияние алкогольной зависимости на течение хронической сердечной недостаточности у больных с ВИЧ-инфекцией</article-title><trans-title-group xml:lang="en"><trans-title>The influence of alcohol dependence on the course of chronic heart failure in patients with HIV infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3336-229X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горячева</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Goryacheva</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Георгиевна Горячева, кандидат медицинских наук, доцент</p><p>кафедра пропедевтики</p><p>Пермь</p></bio><bio xml:lang="en"><p>Olga G. Goryacheva, PhD (Medicine), Associate Professor</p><p>Perm</p></bio><email xlink:type="simple">o.goryacheva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0168-3785</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терехина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Terekhina</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Александровна Терехина, доктор медицинских наук, профессор, завкафедрой</p><p>кафедра биохимии</p><p>Пермь</p></bio><bio xml:lang="en"><p>Natalya A. Terekhina, Doctor of Science (Medicine), Professor</p><p>Perm</p></bio><email xlink:type="simple">terekhina@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5633-0242</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терехин</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Terehin</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Георгий Анатольевич Терехин, доктор медицинских наук, профессор, завкафедрой</p><p>кафедра экстремальной медицины и товароведения</p><p>Пермь</p></bio><bio xml:lang="en"><p>Georgy A. Terehin, Doctor of Science (Medicine), Professor</p><p>Perm</p></bio><email xlink:type="simple">terehin-ga@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Пермский государственный медицинский университет имени академика Е. А. Вагнера</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E. A. Wagner Perm State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Пермская государственная фармацевтическая академия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Perm State Pharmaceutical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>24</day><month>12</month><year>2023</year></pub-date><volume>22</volume><issue>6</issue><fpage>104</fpage><lpage>112</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Горячева О.Г., Терехина Н.А., Терехин Г.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Горячева О.Г., Терехина Н.А., Терехин Г.А.</copyright-holder><copyright-holder xml:lang="en">Goryacheva O.G., Terekhina N.A., Terehin G.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.umjusmu.ru/jour/article/view/1373">https://www.umjusmu.ru/jour/article/view/1373</self-uri><abstract><sec><title>   Введение</title><p>   Введение. Алкогольная зависимость – состояние, последствия которого у лиц с заболеваниями сердечно-сосудистой системы и иммунодефицитом характеризуются тяжелым течением.</p><p>   Цель исследования – оценить влияние алкогольной зависимости на течение хронической сердечной недостаточности у лиц, инфицированных вирусом иммунодефицита человека.</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы. Клиническое исследование с включением 240 больных с ВИЧ-инфекцией, из них у 160 диагностирована хроническая сердечная недостаточность (ХСН), у 72 выявлена алкогольная зависимость. Шкала AUDIT применялась для диагностики алкогольной зависимости. Всем больным проведена эхокардиография, в плазме крови определена концентрация NT-proBNP, в сыворотке – содержание СРБ, трансферрина, ферритина, железа, калия, натрия, билирубина, креатинина, мочевины, мочевой кислоты, активность АСТ, АЛТ, гаммаглута-милтранспептидазы (ГГТП). Статистические расчеты: методы Колмогорова – Смирнова, Манна – Уитни, отношения шансов и рисков.</p></sec><sec><title>   Результаты</title><p>   Результаты. В группе больных с алкогольной зависимостью преобладали застойные явления, более низкая частота сердечных сокращений. На фоне алкогольной зависимости в сыворотке крови установлено снижение уровня общего холестерина, трансферрина, калия, повышение содержания общего билирубина и активности ГГТП, снижение количества тромбоцитов. В плазме крови установлено увеличение концентрации NT-proBNP.</p></sec><sec><title>   Обсуждение</title><p>   Обсуждение. Алкоголю свойственен кардиотоксический эффект, а регулярное употребление этанола сопряжено с развитием неишемической дилатационной кардиомиопатии и ХСН. Эхокардиографические данные свидетельствуют о преобладании дилатации правого предсердия и левого желудочка в группе больных с алкогольной зависимостью среди всех больных с ХСН, инфицированных ВИЧ, вследствие формирования кардиомиопатии.</p></sec><sec><title>   Заключение</title><p>   Заключение. Алкогольная зависимость является состоянием, утяжеляющим течение ХСН у больных с ВИЧ-инфекцией, что проявляется более высокими значениями NT-proBNP плазмы крови, при этом ХСН чаще приобретает застойный характер. Течение ХСН у ВИЧ-инфицированных на фоне алкогольной зависимости сопровождается нарушениями работы печени, в 3,5 раза увеличивается шанс развития холестаза, в 2,5 раза увеличиваются шансы смерти в течение 2 месяцев после поступления в стационар.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Introduction</title><p>   Introduction. Alcohol dependence is a condition, the consequences of which are severe in persons with cardiovascular diseases and immunodeficiency.</p><p>   The purpose of the study is to evaluate the influence of alcohol dependence on the course of chronic heart failure (CHF) in persons infected with human immunodeficiency virus (HIV).</p></sec><sec><title>   Materials and methods</title><p>   Materials and methods. A clinical study including 240 HIV-infected patients, 160 of them were diagnosed with CHF, 72 had alcohol dependence. AUDIIT scale was used for diagnostics of alcohol dependence. All patients underwent echocardiography, NT-proBNP concentration was determined in blood plasma, serum - content of SRB, transferrin, ferritin, iron, potassium, sodium, bilirubin, creatinine, urea, uric acid, AST, ALT, GGTP activity. Statistical calculations: Kolmogorov-Smirnov, Mann-Whitney methods, odds ratios and risks.</p></sec><sec><title>   Results</title><p>   Results. Congestion, lower heart rate prevailed in the group of patients with alcohol dependence. On the background of alcohol dependence in blood serum there was a decrease in the level of total cholesterol, transferrin, potassium, an increase in total bilirubin and GGTP activity, a decrease in the number of platelets. Increase in NT-proBNP concentration was found in blood plasma.</p></sec><sec><title>   Discussion</title><p>   Discussion. Alcohol is characterized by cardiotoxic effect, and regular ethanol consumption is associated with the development of non-ischemic dilated cardiomyopathy and CHF. Echocardiographic findings suggest a predominance of right atrial and left ventricular dilatation in the group of patients with alcohol dependence among all patients with CHF infected with HIV due to the formation of cardiomyopathy.</p></sec><sec><title>   Conclusion</title><p>   Conclusion. Alcohol dependence is a condition aggravating the course of CHF in HIV-infected patients, which is manifested by higher values of blood plasma NT-proBNP, with CHF more often acquiring a congestive character. The course of CHF in HIV-infected patients against the background of alcohol dependence is accompanied by liver dysfunction - 3.5 times increase the chance of cholestasis development, 2.5 times increase the chances of death within 2 months after admission to hospital.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>алкогольная зависимость</kwd><kwd>хроническая сердечная недостаточность</kwd><kwd>ВИЧ-инфекция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>alcohol dependence</kwd><kwd>chronic heart failure</kwd><kwd>HIV infection</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы заявляют об отсутствии внешнего финансирования при проведении исследования</funding-statement><funding-statement xml:lang="en">This study was not supported by any external sources of funding</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Roerecke M. Alcohol’s Impact on the Cardiovascular System. Nutrients. 2021;13(10):3419. doi: 10.3390/nu13103419.</mixed-citation><mixed-citation xml:lang="en">Roerecke M. Alcohol’s Impact on the Cardiovascular System. Nutrients. 2021;13(10):3419. doi: 10.3390/nu13103419.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cífková R, Krajčoviechová A. Alcohol and cardiovascular disease: Position Paper of the Czech Society of Cardiology. Cent Eur J Public Health. 2019;27 Suppl:S6–S9. doi: 10.21101/cejph.a5998.</mixed-citation><mixed-citation xml:lang="en">Cífková R, Krajčoviechová A. Alcohol and cardiovascular disease: Position Paper of the Czech Society of Cardiology. Cent Eur J Public Health. 2019;27 Suppl:S6–S9. doi: 10.21101/cejph.a5998.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Galvan FH, Bing EG, Fleishman JA et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63(2):179–186. doi: 10.15288/jsa.2002.63.179.</mixed-citation><mixed-citation xml:lang="en">Galvan FH, Bing EG, Fleishman JA et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63(2):179–186. doi: 10.15288/jsa.2002.63.179.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Samet JH, Phillips SJ, Horton NJ et al. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses. 2004;20(2):151–155. doi: 10.1089/088922204773004860.</mixed-citation><mixed-citation xml:lang="en">Samet JH, Phillips SJ, Horton NJ et al. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses. 2004;20(2):151–155. doi: 10.1089/088922204773004860.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kelso NE, Sheps DS, Cook RL. The association between alcohol use and cardiovascular disease among people living with HIV : a systematic review. Am J Drug Alcohol Abuse. 2015;41(6):479–488. URL: https://pubmed.ncbi.nlm.nih.gov/26286352/.</mixed-citation><mixed-citation xml:lang="en">Kelso NE, Sheps DS, Cook RL. The association between alcohol use and cardiovascular disease among people living with HIV : a systematic review. Am J Drug Alcohol Abuse. 2015;41(6):479–488. URL: https://pubmed.ncbi.nlm.nih.gov/26286352/.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Andersson C, Schou M, Gustafsson F, Torp-Pedersen C. Alcohol Intake in Patients With Cardiomyopathy and Heart Failure: Consensus and Controversy. Circ Heart Fail. 2022;15(8):e009459. doi: 10.1161/CIRCHEARTFAILURE.121.009459.</mixed-citation><mixed-citation xml:lang="en">Andersson C, Schou M, Gustafsson F, Torp-Pedersen C. Alcohol Intake in Patients With Cardiomyopathy and Heart Failure: Consensus and Controversy. Circ Heart Fail. 2022;15(8):e009459. doi: 10.1161/CIRCHEARTFAILURE.121.009459.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Горячева О.Г., Козиолова Н.А., Терехина Н.А. ВИЧ-ассоциированная патология сердечно-сосудистой системы. Российский кардиологический журнал. 2019;(11):148–154. doi: 10.15829/1560-4071-2019-11-148-154.</mixed-citation><mixed-citation xml:lang="en">Koziolova NA, Goryacheva OG, Terekhina NA. HIV-associated cardiovascular pathology. Russian Journal of Cardiology. 2019;(11):148–154. (In Russ.) doi: 10.15829/1560-4071-2019-11-148-154.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Maisch B. Alcoholic cardiomyopathy: The result of dosage and individual predisposition. Herz. 2016;41(6):484–493. doi: 10.1007/s00059-016-4469-6.</mixed-citation><mixed-citation xml:lang="en">Maisch B. Alcoholic cardiomyopathy: The result of dosage and individual predisposition. Herz. 2016;41(6):484–493. doi: 10.1007/s00059-016-4469-6.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy. Nutrients. 2020;12(2):572. doi: 10.3390/nu12020572.</mixed-citation><mixed-citation xml:lang="en">Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy. Nutrients. 2020;12(2):572. doi: 10.3390/nu12020572.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Терехина Н.А., Терехин Г.А., Жидко Е.В. с соавт. Анализ проницаемости эритроцитарных мембран и активности ферментов холестаза при острой алкогольной интоксикации и обострении хронического панкреатита. Клиническая лабораторная диагностика. 2014;59(9):132.</mixed-citation><mixed-citation xml:lang="en">Terekhina NA, Terekhin GA, Zhidko EV. et al. Analysis of the permeability of erythrocyte membranes and the activity of cholestasis enzymes in acute alcohol intoxication and exacerbation of chronic pancreatitis. Clinical laboratory diagnostics. 2014;59(9):132. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Терехина Н.А., Жидко Е.В., Терехин Г.А., Горячева О.Г. Окислительная модификация белков и показатели антиоксидантной защиты при острой алкогольной интоксикации. Медицинский алфавит. 2017;4(28):53–54.</mixed-citation><mixed-citation xml:lang="en">Teryokhina NA, Zhidko EV, Teryokhin GA, Goryacheva OG. Oxidative modification of proteins and indicators of antioxidant protection in acute alcohol intoxication. Medical alphabet. 2017;4(28):53–54. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Urbano-Marquez A, Estruch R, Navarro-Lopez F et al. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320(7):409–415. doi: 10.1056/NEJM198902163200701.</mixed-citation><mixed-citation xml:lang="en">Urbano-Marquez A, Estruch R, Navarro-Lopez F et al. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320(7):409–415. doi: 10.1056/NEJM198902163200701.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wilke A, Kaiser A, Ferency I, Maisch B. Alcohol and myocarditis. Herz. 1996;21(4):248–257. (In German).</mixed-citation><mixed-citation xml:lang="en">Wilke A, Kaiser A, Ferency I, Maisch B. Alcohol and myocarditis. Herz. 1996;21(4):248–257. (In German).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vary TC, Kimball SR, Sumner A. Sex-dependent differences in the regulation of myocardial protein synthesis following long-term ethanol consumption. Am J Physiol Regul Integr Comp Physiol. 2007;292(2):R778–787. doi: 10.1152/ajpregu.00203.2006.</mixed-citation><mixed-citation xml:lang="en">Vary TC, Kimball SR, Sumner A. Sex-dependent differences in the regulation of myocardial protein synthesis following long-term ethanol consumption. Am J Physiol Regul Integr Comp Physiol. 2007;292(2):R778–787. doi: 10.1152/ajpregu.00203.2006.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mouton AJ, Ninh VK, El Hajj EC et al. Exposure to chronic alcohol accelerates development of wall stress and eccentric remodeling in rats with volume overload. J Mol Cell Cardiol. 2016;97:15–23. doi: 10.1016/j.yjmcc.2016.04.010.</mixed-citation><mixed-citation xml:lang="en">Mouton AJ, Ninh VK, El Hajj EC et al. Exposure to chronic alcohol accelerates development of wall stress and eccentric remodeling in rats with volume overload. J Mol Cell Cardiol. 2016;97:15–23. doi: 10.1016/j.yjmcc.2016.04.010.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez A, Chawla K, Umoh NA et al. Alcohol and Apoptosis: Friends or Foes? Biomolecules. 2015;5(4):3193–3203. doi: 10.3390/biom5043193.</mixed-citation><mixed-citation xml:lang="en">Rodriguez A, Chawla K, Umoh NA et al. Alcohol and Apoptosis: Friends or Foes? Biomolecules. 2015;5(4):3193–3203. doi: 10.3390/biom5043193.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Liu R, Sun F, Armand LC et al. Chronic Ethanol Exposure Induces Deleterious Changes in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. Stem Cell Rev Rep. 2021;17(6):2314–2331. doi: 10.1007/s12015-021-10267-y.</mixed-citation><mixed-citation xml:lang="en">Liu R, Sun F, Armand LC et al. Chronic Ethanol Exposure Induces Deleterious Changes in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. Stem Cell Rev Rep. 2021;17(6):2314–2331. doi: 10.1007/s12015-021-10267-y.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Laurent D, Mathew JE, Mitry M et al. Chronic ethanol consumption increases myocardial mitochondrial DNA mutations: a potential contribution by mitochondrial topoisomerases. Alcohol Alcohol. 2014;49(4):381–389. doi: 10.1093/alcalc/agu029.</mixed-citation><mixed-citation xml:lang="en">Laurent D, Mathew JE, Mitry M et al. Chronic ethanol consumption increases myocardial mitochondrial DNA mutations: a potential contribution by mitochondrial topoisomerases. Alcohol Alcohol. 2014;49(4):381–389. doi: 10.1093/alcalc/agu029.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Piano MR, Phillips SA. Alcoholic cardiomyopathy: pathophysiologic insights. Cardiovasc Toxicol. 2014;14(4):291–308. doi: 10.1007/s12012-014-9252-4.</mixed-citation><mixed-citation xml:lang="en">Piano MR, Phillips SA. Alcoholic cardiomyopathy: pathophysiologic insights. Cardiovasc Toxicol. 2014;14(4):291–308. doi: 10.1007/s12012-014-9252-4.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35(7):1753–1759. doi: 10.1016/s0735-1097(00)00625-2.</mixed-citation><mixed-citation xml:lang="en">Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35(7):1753–1759. doi: 10.1016/s0735-1097(00)00625-2.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Djoussé L, Gaziano JM. Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep. 2008;10(2):117–120. doi: 10.1007/s11883-008-0017-z.</mixed-citation><mixed-citation xml:lang="en">Djoussé L, Gaziano JM. Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep. 2008;10(2):117–120. doi: 10.1007/s11883-008-0017-z.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med. 2004;164(18):1993–1998. doi: 10.1001/archinte.164.18.1993.</mixed-citation><mixed-citation xml:lang="en">Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med. 2004;164(18):1993–1998. doi: 10.1001/archinte.164.18.1993.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kodama S, Saito K, Tanaka S et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol. 2011;57(4):427–436. doi: 10.1016/j.jacc.2010.08.641.</mixed-citation><mixed-citation xml:lang="en">Kodama S, Saito K, Tanaka S et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol. 2011;57(4):427–436. doi: 10.1016/j.jacc.2010.08.641.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mukamal K. Alcohol intake and noncoronary cardiovascular diseases. Ann Epidemiol. 2007;17(5 Suppl):S8–S12. doi: 10.1016/j.annepidem.2007.01.003.</mixed-citation><mixed-citation xml:lang="en">Mukamal K. Alcohol intake and noncoronary cardiovascular diseases. Ann Epidemiol. 2007;17(5 Suppl):S8–S12. doi: 10.1016/j.annepidem.2007.01.003.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pang J, Wang J, Zhang Y et al. Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):1933–1941. doi: 10.1016/j.bbadis.2016.10.004.</mixed-citation><mixed-citation xml:lang="en">Pang J, Wang J, Zhang Y et al. Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):1933–1941. doi: 10.1016/j.bbadis.2016.10.004.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: Cardiohepatic interactions. JACC Heart Fail. 2019;7(2):87–97. doi: 10.1016/j.jchf.2018.10.007.</mixed-citation><mixed-citation xml:lang="en">Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: Cardiohepatic interactions. JACC Heart Fail. 2019;7(2):87–97. doi: 10.1016/j.jchf.2018.10.007.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Voiosu AM, Daha IC, Voiosu TA et al. Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients. Liver Int. 2015;35(12):2547–2555. doi: 10.1111/liv.12866.</mixed-citation><mixed-citation xml:lang="en">Voiosu AM, Daha IC, Voiosu TA et al. Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients. Liver Int. 2015;35(12):2547–2555. doi: 10.1111/liv.12866.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Laurent D, Edwards JG. Alcoholic cardiomyopathy: Multigenic changes underlie cardiovascular dysfunction. J Cardiol Clin Res. 2014;2(1):1022.</mixed-citation><mixed-citation xml:lang="en">Laurent D, Edwards JG. Alcoholic cardiomyopathy: Multigenic changes underlie cardiovascular dysfunction. J Cardiol Clin Res. 2014;2(1):1022.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Seo Y, Aonuma K. Gamma-Glutamyl Transferase as a Risk Biomarker of Cardiovascular Disease — Does It Have Another Face? Circ J. 2017;81(6):783–785. doi: 10.1253/circj.CJ-17-0409.</mixed-citation><mixed-citation xml:lang="en">Seo Y, Aonuma K. Gamma-Glutamyl Transferase as a Risk Biomarker of Cardiovascular Disease — Does It Have Another Face? Circ J. 2017;81(6):783–785. doi: 10.1253/circj.CJ-17-0409.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Терехина Н.А., Терехин Г.А., Жидко Е.В., Горячева О.Г. Окислительная модификация белков, проницаемость эритроцитарных мембран и активность гамма-глутамилтранспептидазы при различных интоксикациях. Медицинская наука и образование Урала. 2019;20(4):78–82. URL: https://revolution.allbest.ru/medicine/01282632_0.html.</mixed-citation><mixed-citation xml:lang="en">Terekhina NA, Terekhin GA, Zhidko EV, Goryacheva OG. Oxidative modification of proteins, permeability of erythrocyte membranes and activity gamma-glutamiltranspeptidase in various intoxications. Medical Science and Education of Ural. 2019;20(4):78–82. URL: https://revolution.allbest.ru/medicine/01282632_0.html.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005;112(14):2078–2080. doi: 10.1161/CIRCULATIONAHA.105.571919.</mixed-citation><mixed-citation xml:lang="en">Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005;112(14):2078–2080. doi: 10.1161/CIRCULATIONAHA.105.571919.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Freiberg MS, McGinnis KA, Kraemer K et al. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2010;53(2):247–253. doi: 10.1097/QAI.0b013e3181c6c4b7.</mixed-citation><mixed-citation xml:lang="en">Freiberg MS, McGinnis KA, Kraemer K et al. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2010;53(2):247–253. doi: 10.1097/QAI.0b013e3181c6c4b7.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Freiberg MS, Chang CC, Kuller LH et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–622. doi: 10.1001/jamainternmed.2013.3728.</mixed-citation><mixed-citation xml:lang="en">Freiberg MS, Chang CC, Kuller LH et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–622. doi: 10.1001/jamainternmed.2013.3728.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Сardiomyopathy. Nutrients. 2020;12(2):572. doi: 10.3390/nu12020572.</mixed-citation><mixed-citation xml:lang="en">Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Сardiomyopathy. Nutrients. 2020;12(2):572. doi: 10.3390/nu12020572.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Armah KA, McGinnis K, Baker J et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012;55(1):126–136. doi: 10.1093/cid/cis406.</mixed-citation><mixed-citation xml:lang="en">Armah KA, McGinnis K, Baker J et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012;55(1):126–136. doi: 10.1093/cid/cis406.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Williams EC, Hahn JA, Saitz R et al. Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res. 2016;40(10):2056–2072. doi: 10.1111/acer.13204.</mixed-citation><mixed-citation xml:lang="en">Williams EC, Hahn JA, Saitz R et al. Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res. 2016;40(10):2056–2072. doi: 10.1111/acer.13204.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Day E, Rudd JHF. Alcohol use disorders and the heart. Addiction. 2019;114(9):1670–1678. doi: 10.1111/add.14703.</mixed-citation><mixed-citation xml:lang="en">Day E, Rudd JHF. Alcohol use disorders and the heart. Addiction. 2019;114(9):1670–1678. doi: 10.1111/add.14703.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Lazarević AM, Nakatani S, Nesković AN et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol. 2000;35(6):1599–1606. doi: 10.1016/s0735-1097(00)00565-9.</mixed-citation><mixed-citation xml:lang="en">Lazarević AM, Nakatani S, Nesković AN et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol. 2000;35(6):1599–1606. doi: 10.1016/s0735-1097(00)00565-9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
